Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Seelos Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 92
- −5 vs. Q4 2021
- Shares held
- 39.5M
- −1.03M (−2.5%) vs. Q4 2021
- Total value
- $33.0M
- −$32.9M (−50.0%) vs. Q4 2021
- New holders
- 14
- 27 more added
- Sold out
- 19
- 28 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SEEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 3 | $4.77K |
| Q3 2024 | 15 | $145.2K |
| Q2 2024 | 23 | $129.4K |
| Q1 2024 | 36 | $1.55M |
| Q4 2023 | 39 | $2.48M |
| Q3 2023 | 82 | $7.01M |
| Q2 2023 | 83 | $27.1M |
| Q1 2023 | 80 | $15.1M |
| Q4 2022 | 80 | $15.6M |
| Q3 2022 | 85 | $28.0M |
| Q2 2022 | 86 | $21.3M |
| Q1 2022 | 92 | $33.0M |
| Q4 2021 | 97 | $65.9M |
| Q3 2021 | 110 | $98.2M |
| Q2 2021 | 105 | $107.8M |
| Q1 2021 | 73 | $124.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Seelos Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DLD Asset Management, LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −15,237−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,985−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −10,005−100.0% | Sold out |
| Asset Management Corp | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Rinkey Investments | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| TAP Consulting, LLC | 0 | $0 | 0.00% | −1,035−100.0% | Sold out |
| Resolute Partners Group | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −557−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −24,673−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |